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Abstract
Background: Leprosy is a chronic granulomatous infectious disease having major burden on 
humans over thousands of years. If untreated, it results in permanent damage to various systems 
and organs. So we designed this study to evaluate the neurological complications in early stage in 
adult leprosy patients. Objective: The aim of this study was to find out the pattern of neurological 
manifestations among adult leprosy patients. Materials and Methods: This cross-sectional 
hospital-based study on 85 adult tribal leprosy patients was conducted in a district level health 
care facility from January to December 2014 using simple, direct, standardized questionnaire 
including history and neurological examinations. Results: The commonest age group affected was 
18–30 years (62.4%). Male group was predominant (68.2%). Majority cases (66%) had 
multibacillary leprosy. At first visit 72.7% cases with neurological findings could not be diagnosed 
correctly by primary health care personnel. More than six months were required for correct 
diagnosis in 61.2% cases. Numbness was the commonest (74.5%) neurological symptom. In upper 
limb, motor findings were predominant with wasting in 50.9% cases. In lower limb, sensory 
findings were predominant with stock pattern sensory impairment being the commonest (56.4%). 
Ulnar nerve was the commonest peripheral nerve to enlarge with tenderness. Facial nerve was the 
commonest cranial nerve involved. All cases with multiple cranial nerves involvement were of 
multibacillary type. Due to physical disability 92.7% cases lost their jobs. Conclusion: In this 
study neurological involvement was found associated with severe disability. 
Key words:  Leprosy; Numbness; Neuropathy; Disability
J Enam Med Col 2016; 6(1): 10–14
Leprosy is a chronic granulomatous infectious disease 
that has been a major burden on human over thousands 
of years.1 If untreated, the disease is progressive and 
results in permanent damage to the skin, nerves, limbs 
and eyes.1 It was recognized in the ancient civilizations 
of China, Egypt and India. The earliest report of leprosy 
dated back to 600 BC.2 Perhaps no other disease in the 
history of mankind has been associated with such a 
strong social stigma as leprosy. Failure in early 
detection often leads to severe disability in spite of 
eradication of mycobacterium at a later date.3,4 The 
most likely mode of transmission is through nasal 
secretions and skin contact. The disease is thought to be 
of low infectivity. In most populations, over 95% of 
individuals are naturally immune. In spite of this the 
disease accounts for approximately 10 million affected 
people worldwide.5 Leprosy remained an incurable 
disease until 1940 when the first breakthrough occurred 
with the development of dapsone, a drug capable of 
arresting the disease.6 Today it is widely accepted that 
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multi-drug therapy (MDT) renders leprosy curable. 
With neurological complications leprosy causes more 
disability and increases burden to society. In developing 
countries there are not enough qualified healthcare 
personnel to detect the neurological complications in 
early stage of disease. With history, investigations and 
examination the neurological complications can be 
detected in the early stage. The aim of this study was to 
find out the pattern of neurological manifestations of 
leprosy in adults that can help to make early diagnosis 
of this disease and prevent devastating complications. 
Materials and Methods
This cross-sectional study was based on the interview 
and examination of the patients presented with the 
features of leprosy in the outpatient department. Total 
85 subjects were included in this study. The study 
population included all those tribal patients who were 
diagnosed as leprosy cases at Rangamati Sadar Hospital 
during one year period from January to December 2014. 
Patients below 18 years of age were excluded. All the 
patients gave their consent to participate in the study. 
Detailed history was taken and proper systemic and 
neurological examinations were performed. The 
physical signs were grouped into general, systemic, 
dermatological and neurological. According to WHO, 
diagnosis of leprosy is clinical and is based on patients 
having one or more of three cardinal signs: i) 
hypopigmented or reddish patches with definite loss of 
sensation, ii) thickened peripheral nerves and iii) acid-
fast bacilli on skin smears or biopsy material.7 
Investigations were needed only in cases where the 
diagnosis was doubtful or where recurrence was 
suspected. The disease is classified into paucibacillary 
(PB) and multibacillary (MB) leprosy according to 
WHO classification and standard regimens of MDT 
according to WHO therapeutic guidelines were used for 
the treatment of the patients included in the study.8 The 
following drugs were used: rifampicin, dapsone and 
clofazimine. Neurological complications were searched 
thoroughly by central and peripheral nervous system 
examinations. Data were collected, tabulated and 
statistical analysis was performed using software SPSS 
16.0 for Windows.
Results
Among the 85 patients diagnosed as leprosy,  
multibacillary type was predominant (65.9%, n=56) and 
remaining 29 cases were paucibacillary. Among the 
cases, 55 (64.7%) presented with different neurological 
signs and symptoms, that is, the prevalence of 
neurological manifestation is high.
Table I shows the socio-demographic factors of leprosy 
patients.  We found that 53 (62.4%) patients were aged 
between 18–30 years. Among the study subjects 68.2% 
were male, 61.2% were from rural area, 75.3% were 
previously employed, 72.9% had previous BCG 
vaccination and four patients had previous positive 
family history. Only one patient had previously 
diagnosed neurological disease. After 6 months of 
clinical manifestations, 61.2% were diagnosed 
correctly. 
Table I:  Distribution of leprosy patients according to 
socio-demographic factors (N=85)
 Socio-demographic factors Number Percentage
 Age (years) 
 18–30 53  62.4 
 31–45 18 21.2 
 46–60 11 12.9
 >60 3   3.5
 Sex 
 Male 58 68.2
 Female 27 31.8 
 Residence
 Urban 33 38.8
 Rural 52 61.2
 Previous employment 
 Employed 64  75.3 
 Unemployed 21  24.7 
 BCG vaccination 
 Yes 62 72.9
 No 18 21.2
 Not known 5   5.9
 Positive family history
 Yes 4   4.7
 No 81 95.3
 Past primary neurological disease
 Yes 1   1.2
 No 84 98.8
 Duration before diagnosis
 <6 months 33 38.8
 >6 months 52 61.2
On first visit to primary care personnel, out of 55 
subjects with neurological complications only 15 
(27.3%) cases were diagnosed properly, 40 (72.7%) 
cases could not be diagnosed or diagnosed wrongly 
leading to delay in initiation of treatment.
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In our study we found 9 types of neurological 
symptoms in leprosy patients (Fig 1). Numbness 
was the commonest symptom (n=41, 74.5%). Limb 
weakness was found in 31 cases (56.4%) involving 
the upper limb and 24 cases (43.6%) involving the 
lower limb. Neuropathic pain was found in 14 
patients. Other less common symptoms were upper 
and lower limb weakness, smelling disturbance, 
visual disturbance, headache and facial palsy.  One 
patient complained of convulsion which was not 
fully investigated. 
Fig 1. The common presenting neurological 
symptoms (some patients presented with 
multiple symptoms)
On proper examination and investigations for 
neurological deficits in upper limb we found that 
motor deficit was predominant compared with 
sensory deficits (Table II). Multibacillary (MB) 
cases showed more neurological findings. The 
commonest motor finding was wasting of muscles 
(n=28, 50.9%). Ulnar nerve weakness (45.6%) and 
median nerve weakness (38.2%) were also common. 
‘Gloves’ pattern impairment (n= 12, 21.8%) was the 
commonest sensory impairment. Other common 
neurological findings were ulnar weakness (38.2%) 
and median weakness (21.8%). Less common 
findings were true claw, ulnar claw, loss of finger 
phalanges, simian deformity, hypotonia, 
hyporeflexia, ulcers, ulnar sensory impairment, 
median and radial cutaneous sensory impairment. 
Table II: Neurological findings of leprosy in upper limbs (n=55)
 Clinical findings MB PB Total
Number (%) Number (%) Number (%)
 Wasting 23 (41.8) 5 (9.1) 28  (50.9)
 Ulnar weakness 20 (36.4) 5 (9.1) 25 (45.6)
 Median weakness 16 (29.1) 5 (9.1) 21 (38.2)
 ‘Gloves’ pattern sensory 9 (16.4) 3 (5.5) 12 (21.8)
 impairment
 True claw 7 (12.7) 1 (1.8) 8 (14.5)
 Ulnar claw 3 (5.5) 2 (3.6) 5 (9.1)
 Hypotonia 3 (5.5) 2 (3.6) 5 (9.1)
 Hyporeflexia 3 (5.5) 0 (0.0) 3 (5.5)
 Simian deformity 2 (3.6) 1 (1.8) 3 (5.5)
 Ulcers 2 (3.6) 0 (0.0) 2 (3.6)
 Ulnar sensory impairment 2 (3.6) 0 (0.0) 2 (3.6)
 Median sensory impairment 2 (3.6) 0 (0.0) 2 (3.6)
 Radial cutaneous sensory 1 (1.8) 0 (0.0) 1 (1.8)
 impairment
MB, Multibacillary; PB, Paucibacillary
Our study also revealed neurological findings in lower 
limbs where sensory findings were more than motor 
findings (Table III). Again multibacillary cases showed 
more neurological findings. ‘Stocks’ pattern sensory 
impairment was the commonest (n=31, 56.4%). Wasting 
(n=19, 34.5%) was the commonest motor finding. Nine 
cases showed deep ulcers in feet due to sensory 
impairment. 
Table III: Neurological findings of leprosy in lower limbs (n=55)
 Clinical findings MB PB Total 
Number (%) Number (%) Number (%)
 ‘Stocks’ pattern sensory 26 (47.3) 5 (9.1) 31 (56.4)
 impairment
 Wasting 15 (27.3) 4 (7.3) 19 (34.5)
 Deep ulcers 6 (10.9) 3 (5.5) 9 (16.4)
 Lateral popliteal sensory 4 (7.3) 2 (3.6) 6 (10.9)
 impairment
 Posterior tibial sensory impairment 4 (7.3) 1 (1.8) 5 (9.1)
 Loss of toe phalanges 2 (3.6) 1 (1.8) 3 (5.5)
 Drop feet 2 (3.6) 0 (0.0) 2 (3.6)
 Posterior tibial weakness 2 (3.6) 0 (0.0) 2 (3.6)
 Lateral poplitial weakness 1 (1.8) 0 (0.0) 1 (1.8)
 Hypotonia 1 (1.8) 0 (0.0) 1 (1.8)
 Impaired co-ordination 1 (1.8) 0 (0.0) 1 (1.8)
MB, Multibacillary; PB, Paucibacillary
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Enlarged nerve was found on palpation. Tenderness was 
also elicited in some enlarged cases. Commonest nerve 
involved was ulnar nerve (n=22). Great auricular nerve, 
radial cutaneous nerve, lateral poplitial nerve, posterior 
tibial nerve involvement was also found (Table IV).
Table IV: Involvement of nerves in leprosy 
 Nerve Enlarged Tender
 Ulnar nerve 22 13
 Great auricular nerve 18 9
 Radial cutaneous nerve 11 5
 Lateral popliteal nerve 9 6
 Posterior tibial nerve 11 7
Eight cases (14.54%) were found with cranial nerve 
involvement in our study. Multibacillary (MB) cases 
were more vulnerable for cranial nerve involvement. 
Facial nerve involvement was the commonest (n=6, 
10.9%). Trigeminal, olfactory and auditory nerve 
involvement was also found (Table V).
Table V: Cranial nerve involvement in leprosy patients
 Cranial nerves MB PB Total
 Facial nerve 4 2 6
 Trigeminal nerve 2 1 3
 Olfactory nerve 2 0 2
 Auditory nerve 1 0 1
MB, Multibacillary; PB, Paucibacillary
Single cranial nerve involvement was found in most 
cases (n=5, 9.9%). Double (n=2) or triple (n=1) cranial 
nerve involvement was found only in multibacillary 
cases (Table VI). Due to delay in treatment with 
neurological complications most of the patients suffered 
from physical disabilities. Fifty one cases (92.7%) lost 
their job or business. They also suffered from physical 
dependence, immobility, pain and hampered regular 
activities (Fig 2).
Table VI:  Number of cranial nerves involved in leprosy 
subjects
 Cranial nerve number MB PB Total
  1 2 3 5
  2 2 0 2
>2 1 0 1
MB, Multibacillary; PB, Paucibacillary
Fig 2. Physical disability with neurological 
complications in leprosy patients (some 
patients had multiple complications)
Discussion
This study showed that males were affected more than 
females. This finding is similar to what have been found 
worldwide.8  It appeared in this study that the age group 
18–30 years is affected  most commonly; this is similar 
to finding in another study.9  This group being the most 
active component of the community highlights the need 
for early detection and treatment of the disease. The 
prevalence was found decreased (3.5%) in the age 
group >60 years. 
In our study most of the patients had no family history 
of leprosy, this is similar to a study done in Ethiopia10 
and it differs from what was mentioned in the study 
done in Nepal where positive family history was found 
in up to 50% cases.11 We assume that family history is 
very important because proximity to leprosy patients is 
an important determinant of transmission. Considerable 
number of our patients had no sensory impairment over 
skin lesions, this may be explained by the fact that 
sensory impairment over skin lesions is an uncommon 
and a late feature of the MB form of the disease. 
Numbness and weakness of the limbs (77.14%, 
31.43%) were the most common neurological 
symptoms similar to what was mentioned elsewhere.12 
This is because leprosy affects peripheral nerves 
leading to sensory disturbance and weakness in addition 
to destruction of bones. Lower motor neuron facial 
weakness and trigeminal nerve involvement were 
found, which is similar to what was reported earlier.13
Olfactory and auditory nerves involvement was found in 
a few cases in this study. It is less than what was 
mentioned in a study done in Nepal.14 Examination of 
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upper and lower limbs revealed that wasting, upper limb 
weakness and sensory disturbance were the commonest 
signs. In upper limbs, half of the patients (50.9%) had 
some degree of wasting. Motor dysfunction was 
predominant in the upper limb, but this is not similar to 
the study done in Nigeria9 and Canada.15 In the lower 
limbs, sensory nerve dysfunction with stocks pattern 
was the commonest sensory dysfunction detected in 
majority (56.4%) cases. This finding is similar to that in 
the study done by Boggild et al.15 From previous 
studies it seems that our patients were more affected 
neurologically. This can be explained by delayed 
presentation of our patients and by the fact that most of 
our patients had MB form of leprosy. Ulnar nerve was 
found enlarged in maximum number of cases followed 
by the great auricular nerve and radial cutaneous nerve. 
This is slightly different from what was mentioned in 
the literature.16 
Finally, in this study neurological involvement was 
found associated with severe disability. Severe 
complications and permanent disabilities can be 
reduced by early diagnosis and management. Tribal 
community people should be screened regularly for 
leprosy and health care personnel including doctors 
should be trained to make them aware of the different 
neurological presentations of this disabling disease. 
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